Accueil > Publications > ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of C...